New
HealthMore in Health→
Heart and Anticoagulant Drug Use Shifts as Alzheimer's and Parkinson's Advance
Key Takeaways
- A University of Eastern Finland doctoral study by Barkat Babar examined oral anticoagulant and cardiovascular drug use among people with Alzheimer's and Parkinson's disease in Finland, five years before and five years after diagnosis.
- Among people with Alzheimer's disease, oral anticoagulant use increased before diagnosis but declined afterward, possibly due to safety concerns such as falls and other adverse events.
- Among people with Parkinson's disease, oral anticoagulant use remained relatively stable after diagnosis, suggesting clinicians judged the benefits to outweigh the risks.
- Cardiovascular drug use declined after a Parkinson's diagnosis, potentially linked to progression symptoms such as orthostatic hypotension and weight loss.
DE
DT Editorial Team··via medicalxpress.com
